What are the major opportunities in the Ultomiris market? What are the strategies for the Ultomiris market?

For detailed insights on the major opportunities and strategies in the Ultomiris market, Read More

How does the Ultomiris market relate to the overall economy and other similar markets?

For detailed insights on Ultomiris's relation to the overall economy and other similar markets, Read More

What are the latest mergers and acquisitions in the Ultomiris industry?

For detailed insights on the mergers and acquisitions in the Ultomiris industry, Read More

What are the key dynamics influencing the Ultomiris market growth? SWOT analysis of the Ultomiris market.

For detailed insights on the key dynamics influencing the Ultomiris market growth and SWOT analysis of the Ultomiris industry, Read More

Item added to cart!

Report Price : $4490.00

Pages :

Format : PDF

Published : December 2025

Delivery Time : 2-3 Business Days

Purchase This Report Download Sample PDF

Purchase This Report

Ultomiris Global Market Report 2025

Name: Ultomiris Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Indication (Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS), Generalized Myasthenia Gravis (gMG), Neuromyelitis Optica Spectrum Disorder (NMOSD)), By Formulation (Intravenous Solution, Subcutaneous Formulation), By Distribution Channel (Hospital And Clinics, Retail And Specialty Pharmacies), By End User (Adult Patients, Pediatric Patients)

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Ultomiris Market?

Ultomiris is a prescription medication with the active ingredient ravulizumab-cwvz, a monoclonal antibody that inhibits a component of the immune system known as C5 in the complement cascade. It treats certain rare and severe autoimmune diseases by preventing the immune system from attacking healthy cells.

The main types of clinical indications in ultomiris are paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS), generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired disorder where red blood cells are destroyed prematurely, leading to hemolysis and blood clotting. It includes various formulations, such as intravenous solutions and subcutaneous formulations, and is distributed through hospitals and clinics and retail and specialty pharmacies. It caters to various end users, such as adult patients and pediatric patients.

Ultomiris Market Size and growth rate 2025 to 2029: Graph

What Is The Ultomiris Market Size 2025 And Growth Rate?

The ultomiris market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing the demand for biologics, increasing applications of mAb therapies, increasing prevalence of autoimmune conditions, and rising prevalence of PNH.

What Is The Ultomiris Market Growth Forecast?

The ultomiris market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing burden on healthcare systems, rising incidences of arthritis and inflammatory diseases, rising investments in research, increasing numbers of drug approvals, and increasing prevalence of musculoskeletal disorders. Major trends in the forecast period include advanced hospital infrastructure, advancement in treatment options, strategic research collaborations, development of orphan drugs, and expansion into new indications.

Book your 30 minutes free consultation with our research experts

How Is The Ultomiris Market Segmented?

The ultomiris market covered in this report is segmented –

1) By Indication: Paroxysmal Nocturnal Hemoglobinuria (PNH); Atypical Hemolytic Uremic Syndrome (aHUS); Generalized Myasthenia Gravis (gMG); Neuromyelitis Optica Spectrum Disorder (NMOSD)

2) By Formulation: Intravenous Solution; Subcutaneous Formulation

3) By Distribution Channel: Hospital And Clinics; Retail And Specialty Pharmacies

4) By End User: Adult Patients; Pediatric Patients

What Is Driving The Ultomiris Market? Impact Of Increasing Autoimmune Conditions On The Growth Of The Market

The increasing prevalence of autoimmune conditions is expected to propel the growth of the ultomiris market going forward. Autoimmune conditions refer to disorders in which the immune system mistakenly attacks and damages the body’s healthy cells and tissues. The increasing prevalence of autoimmune conditions can be attributed to both environmental factors, such as exposure to pollutants and chemicals, and improved diagnosis, which has led to more people being identified and treated for these diseases. Ultomiris treats autoimmune conditions such as Paroxysmal Nocturnal Hemoglobinuria (PNH) and Atypical Hemolytic Uremic Syndrome (aHUS) by inhibiting complement protein C5, reducing immune attacks on the body. For instance, in June 2024, according to a report published by the Australian Institute of Health and Welfare, an Australian-based governmental organization, in 2022, there were 10,000 hospitalizations for rheumatoid arthritis (an autoimmune disease), marking a 25% increase from 8,000 in the previous year, with a hospitalization rate of 39 per 100,000 people. Therefore, the increasing prevalence of autoimmune conditions is driving the growth of the ultomiris market.

What Is Driving The Ultomiris Market? Impact Of Rising Healthcare Expenditure On The Market Growth

The rising healthcare expenditure is expected to propel the growth of the ultomiris market going forward. Healthcare expenditure refers to the financial resources spent on a country or region's medical services, infrastructure, insurance, and related activities. The rise in healthcare expenditure is due to the aging population and the increasing prevalence of chronic diseases, leading to higher ongoing medical management costs. Healthcare expenditure for ultomiris is used to cover the cost of the drug, its administration, patient monitoring, and continuing research and development to expand its therapeutic indications. For instance, in May 2024, according to the Office for National Statistics, a UK-based government department, healthcare expenditure in the USA rose by 5.6% in nominal terms from 2022 to 2023, marking a significant increase compared to the 0.9% growth observed in 2022. Therefore, rising healthcare expenditure is expected to propel the growth of the ultomiris market.

Who Are The Major Players In The Global Ultomiris Market?

Major companies operating in the ultomiris market are AstraZeneca Plc.

What Are The Key Trends Of The Global Ultomiris Market? Drug Approval For Ultomiris In Neuromyelitis Optica Spectrum Disorder (NMOSD)

The key trend in the ultomiris market is drug approval from regulatory authorities to expand its therapeutic indications and market reach. Drug approval is the process by which regulatory authorities evaluate and authorize a new drug for sale and use, ensuring its safety, efficacy, and quality based on clinical trial data. For instance, in March 2024, AstraZeneca, a UK-based pharmaceutical industry company, received the Food and Drug Administration (FDA) approval for ULTOMIRIS (ravulizumab-cwvz) for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD) who are favorable for the anti-aquaporin-4 (AQP4) antibody. This approval is significant as ULTOMIRIS is the first long-acting C5 complement inhibitor for NMOSD, shown to reduce relapse risk by 98.6% in clinical trials. ULTOMIRIS helps prevent immune attacks on the central nervous system by inhibiting the complement system. However, it carries risks, including serious meningococcal infections and common side effects such as headache and urinary tract infections.

Need data on a specific region in this market?

Request Regional Data

Regional Analysis For The Global Ultomiris Market

North America was the largest region in the ultomiris market in 2024. The regions covered in the ultomiris market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the ultomiris market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

What Defines the Ultomiris Market?

The ultomiris market consists of sales of ultomiris injections, alpha-1 proteinase inhibitors, subcutaneous injections, and monoclonal antibodies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Ultomiris Industry?

The ultomiris market research report is one of a series of new reports from The Business Research Company that provides ultomiris market statistics, including ultomiris industry global market size, regional shares, competitors with ultomiris market share, detailed ultomiris market segments, market trends and opportunities, and any further data you may need to thrive in the ultomiris industry. This ultomiris market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Ultomiris Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	Included ?
Revenue Forecast In 2034	Included ?
Growth Rate	Included ?
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The ultomiris market covered in this report is segmented – 1) By Indication: Paroxysmal Nocturnal Hemoglobinuria (PNH); Atypical Hemolytic Uremic Syndrome (aHUS); Generalized Myasthenia Gravis (gMG); Neuromyelitis Optica Spectrum Disorder (NMOSD) 2) By Formulation: Intravenous Solution; Subcutaneous Formulation 3) By Distribution Channel: Hospital And Clinics; Retail And Specialty Pharmacies 4) By End User: Adult Patients; Pediatric Patients
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	AstraZeneca Plc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Ultomiris Market Characteristics

3. Ultomiris Market Biologic Drug Characteristics

3.1. Molecule Type

3.2. Route Of Administration (ROA)

3.3. Mechanism Of Action (MOA)

3.4. Safety And Efficacy

4. Ultomiris Market Trends And Strategies

5. Ultomiris Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

6. Global Ultomiris Growth Analysis And Strategic Analysis Framework

6.1. Global Ultomiris PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

6.2. Analysis Of End Use Industries

6.3. Global Ultomiris Market Growth Rate Analysis

6.4. Global Ultomiris Historic Market Size and Growth, 2019 - 2024, Value ($ Million)

6.5. Global Ultomiris Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Million)

6.6. Global Ultomiris Total Addressable Market (TAM)

7. Global Ultomiris Pricing Analysis & Forecasts

8. Ultomiris Market Segmentation

8.1. Global Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Paroxysmal Nocturnal Hemoglobinuria (PNH)

Atypical Hemolytic Uremic Syndrome (aHUS)

Generalized Myasthenia Gravis (gMG)

Neuromyelitis Optica Spectrum Disorder (NMOSD)

8.2. Global Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Intravenous Solution

Subcutaneous Formulation

8.3. Global Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Hospital And Clinics

Retail And Specialty Pharmacies

8.4. Global Ultomiris Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Adult Patients

Pediatric Patients

9. Global Ultomiris Epidemiology Of Clinical Indications

9.1. Drug Side Effects

9.2. Incidence And Prevalence of Clinical Indications

10. Ultomiris Market Regional And Country Analysis

10.1. Global Ultomiris Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

10.2. Global Ultomiris Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11. Asia-Pacific Ultomiris Market

11.1. Asia-Pacific Ultomiris Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.3. Asia-Pacific Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

11.4. Asia-Pacific Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

12. China Ultomiris Market

12.1. China Ultomiris Market Overview

12.2. China Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.3. China Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

12.4. China Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Million

13. India Ultomiris Market

13.1. India Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.2. India Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

13.3. India Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14. Japan Ultomiris Market

14.1. Japan Ultomiris Market Overview

14.2. Japan Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.3. Japan Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

14.4. Japan Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15. Australia Ultomiris Market

15.1. Australia Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.2. Australia Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

15.3. Australia Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16. South Korea Ultomiris Market

16.1. South Korea Ultomiris Market Overview

16.2. South Korea Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.3. South Korea Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

16.4. South Korea Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17. Western Europe Ultomiris Market

17.1. Western Europe Ultomiris Market Overview

17.2. Western Europe Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.3. Western Europe Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

17.4. Western Europe Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18. UK Ultomiris Market

18.1. UK Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.2. UK Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

18.3. UK Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19. Germany Ultomiris Market

19.1. Germany Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.2. Germany Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

19.3. Germany Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20. France Ultomiris Market

20.1. France Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.2. France Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

20.3. France Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21. Eastern Europe Ultomiris Market

21.1. Eastern Europe Ultomiris Market Overview

21.2. Eastern Europe Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.3. Eastern Europe Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

21.4. Eastern Europe Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22. North America Ultomiris Market

22.1. North America Ultomiris Market Overview

22.2. North America Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.3. North America Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

22.4. North America Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23. USA Ultomiris Market

23.1. USA Ultomiris Market Overview

23.2. USA Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.3. USA Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

23.4. USA Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24. Canada Ultomiris Market

24.1. Canada Ultomiris Market Overview

24.2. Canada Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.3. Canada Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

24.4. Canada Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25. South America Ultomiris Market

25.1. South America Ultomiris Market Overview

25.2. South America Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.3. South America Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

25.4. South America Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26. Middle East Ultomiris Market

26.1. Middle East Ultomiris Market Overview

26.2. Middle East Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.3. Middle East Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

26.4. Middle East Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27. Africa Ultomiris Market

27.1. Africa Ultomiris Market Overview

27.2. Africa Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.3. Africa Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

27.4. Africa Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

28. Ultomiris Market Competitive Landscape And Company Profiles

28.1. Ultomiris Market Competitive Landscape

28.2. Ultomiris Market Company Profiles

28.2.1. AstraZeneca Plc. Overview, Products and Services, Strategy and Financial Analysis

29. Global Ultomiris Market Pipeline Analysis

29.1. High Level Clinic Trail Information

30. Global Ultomiris Market Competitive Benchmarking And Dashboard

31. Key Mergers And Acquisitions In The Ultomiris Market

32. Recent Developments In The Ultomiris Market

33. Ultomiris Market High Potential Countries, Segments and Strategies

33.1 Ultomiris Market In 2029 - Countries Offering Most New Opportunities

33.2 Ultomiris Market In 2029 - Segments Offering Most New Opportunities

33.3 Ultomiris Market In 2029 - Growth Strategies

33.3.1 Market Trend Based Strategies

33.3.2 Competitor Strategies

34. Appendix

34.1. Abbreviations

34.2. Currencies

34.3. Historic And Forecast Inflation Rates

34.4. Research Inquiries

34.5. The Business Research Company

34.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Million

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Table 3: Global Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 4: Global Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 5: Global Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 6: Global Ultomiris Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 7: Global Ultomiris Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 8: Global Ultomiris Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 9: Asia-Pacific, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 10: Asia-Pacific, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 11: Asia-Pacific, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 12: China, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 13: China, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 14: China, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 15: India, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 16: India, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 17: India, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 18: Japan, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 19: Japan, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 20: Japan, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 21: Australia, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 22: Australia, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 23: Australia, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 24: South Korea, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 25: South Korea, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 26: South Korea, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 27: Western Europe, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 28: Western Europe, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 29: Western Europe, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 30: UK, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 31: UK, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 32: UK, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 33: Germany, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 34: Germany, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 35: Germany, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 36: France, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 37: France, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 38: France, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 39: Eastern Europe, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 40: Eastern Europe, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 41: Eastern Europe, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 42: North America, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 43: North America, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 44: North America, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 45: USA, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 46: USA, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 47: USA, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 48: Canada, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 49: Canada, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 50: Canada, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 51: South America, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 52: South America, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 53: South America, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 54: Middle East, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 55: Middle East, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 56: Middle East, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 57: Africa, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 58: Africa, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 59: Africa, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Table 60: AstraZeneca Plc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Million

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Million

Figure 3: Global Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 4: Global Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 5: Global Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 6: Global Ultomiris Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 7: Global Ultomiris Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 8: Global Ultomiris Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 9: Asia-Pacific, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 10: Asia-Pacific, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 11: Asia-Pacific, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 12: China, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 13: China, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 14: China, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 15: India, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 16: India, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 17: India, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 18: Japan, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 19: Japan, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 20: Japan, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 21: Australia, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 22: Australia, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 23: Australia, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 24: South Korea, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 25: South Korea, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 26: South Korea, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 27: Western Europe, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 28: Western Europe, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 29: Western Europe, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 30: UK, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 31: UK, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 32: UK, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 33: Germany, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 34: Germany, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 35: Germany, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 36: France, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 37: France, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 38: France, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 39: Eastern Europe, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 40: Eastern Europe, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 41: Eastern Europe, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 42: North America, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 43: North America, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 44: North America, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 45: USA, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 46: USA, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 47: USA, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 48: Canada, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 49: Canada, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 50: Canada, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 51: South America, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 52: South America, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 53: South America, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 54: Middle East, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 55: Middle East, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 56: Middle East, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 57: Africa, Ultomiris Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 58: Africa, Ultomiris Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 59: Africa, Ultomiris Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Million

Figure 60: AstraZeneca Plc. Financial Performance

Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Outlook 2025: Mapping Growth, Innovation, and Regional Shifts

Global Vutrisiran Market Trends: Regional Breakdowns and Strategic Insights

Vyndaqel Outlook 2034: Key Drivers, Trends, and Market Frontiers

Functional Dyspepsia DrugMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Discover key trends and market dynamics in the Smoking Cessation & Nicotine De-addiction Products Market with 2025 insights from The Business Research Company.

Autoimmune Disease Diagnosis Market 2022 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals), By Test Type (Routine Laboratory Tests, Autoantibodies Tests, Immunologic T...

G-CSF (Granulocyte Colony Stimulating Factors) Market 2021 - By Type (Pegfilgrastim, Filgrastim, Lenograstim), By Application (Oncology, Blood Disorders, Chronic and Autoimmune Disorders), And By Region, Opportunities An...

Autoimmune Disease Diagnosis Global Market Report 2025 – By Product (Consumables And Assay Kits, Instruments), By End User (Clinical Laboratories, Hospitals, Others), By Test Type (Routine Laboratory Tests, Autoantibodie...

Autoimmune Treatment Global Market Report 2025 – By Product (Consumables and Assay Kits, Instruments, Services), By Service Type (Consultation and Diagnosis, Therapy and monitoring, Drug development), By Disease (Rheumat...

Immune Health Supplements Global Market Report 2025 – By Ingredients Type( Vitamins, Minerals, Herbal Botanical Extracts, Probiotics, Amino Acids, Omega 3 - Fatty Acids), By Form( Soft Gels Or Capsules, Tablets, Powder, ...

PD-1 and PDL1 Inhibitors/ Immune Checkpoint Inhibitors Global Market Report 2025 – By Product (Nivolumab, Pembrolizumab, Atezolizumab, Avelumab, Durvalumab), By Distribution Channel (Hospital pharmacies, Retail pharmacie...

Insulin Drugs Global Market Report 2025 – By Product Type (Basal Or Long-Acting Insulins, Bolus Or Fast-Acting Insulins, Pre-Mixed, And Intermediate And Short Acting Insulins), By Source Type (Insulin Analogs, And Human ...

Frequently Asked Questions

What is the definition of the Ultomiris market?

How will the Ultomiris market drivers and restraints affect the market dynamics? What forces will shape the Ultomiris industry going forward?

The Ultomiris market major growth driver - Impact Of Increasing Autoimmune Conditions On The Growth Of The Market. For further insights on the Ultomiris market, request a sample here

What is the forecast market size or the forecast market value of the Ultomiris market?

The Ultomiris market size has grown strongly in recent years. The ultomiris market size has XX (HCAGR) in recent years. It will grow from $XX million in 2024 to $XX million in 2025 at a compound annual growth rate (CAGR) of XX%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, increasing the demand for biologics, increasing applications of mAb therapies, increasing prevalence of autoimmune conditions, and rising prevalence of PNH. The ultomiris market size is expected to see XX (FCAGR) in the next few years. It will grow to $XX million in 2029 at a compound annual growth rate (CAGR) of XX%. The growth in the forecast period can be attributed to increasing burden on healthcare systems, rising incidences of arthritis and inflammatory diseases, rising investments in research, increasing numbers of drug approvals, and increasing prevalence of musculoskeletal disorders. Major trends in the forecast period include advanced hospital infrastructure, advancement in treatment options, strategic research collaborations, development of orphan drugs, and expansion into new indications. For further insights on the Ultomiris market, request a sample here

How is the Ultomiris market segmented?

The ultomiris market covered in this report is segmented –
1) By Indication: Paroxysmal Nocturnal Hemoglobinuria (PNH); Atypical Hemolytic Uremic Syndrome (aHUS); Generalized Myasthenia Gravis (gMG); Neuromyelitis Optica Spectrum Disorder (NMOSD)
2) By Formulation: Intravenous Solution; Subcutaneous Formulation
3) By Distribution Channel: Hospital And Clinics; Retail And Specialty Pharmacies
4) By End User: Adult Patients; Pediatric Patients For further insights on the Ultomiris market, request a sample here

Which region has the largest share of the Ultomiris market? What are the other regions covered in the report?

Who are the major players in the Ultomiris market?

Major companies operating in the ultomiris market are AstraZeneca Plc. . For further insights on the Ultomiris market, request a sample here.

What are the key trends in the Ultomiris market?

Major trends in the Ultomiris market include Drug Approval For Ultomiris In Neuromyelitis Optica Spectrum Disorder (NMOSD). For further insights on the Ultomiris market, request a sample here.